Funded Project Details - FY2021
|Title:|| Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C|
Susan Lynn Uprichard
|Congressional District Code:
||Clinical Science R&D
|| July 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
The rationale for this application is to take action to improve/expand HCV treatment options, an issue that effects ~10% of veterans. While chronic HCV infection can lead to liver steatosis, insulin resistance, chronic inflammation, and fibrosis, and hepatocellular carcinoma, the astronomical cost of the new HCV antivirals represents a significant burden on the VA healthcare system and the risk of viral escape has not been determined in less than ideal compliance populations. To address the need...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.